Becton, Dickinson and Co. | BDX - Equity Capital And Reserves

Stock Price
206.62
Daily Change
-1.25 -0.60%
Monthly
0.61%
Yearly
-9.06%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $25.39B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Agilent USD 6.74B 371M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
Avanos Medical USD 778M 1.7M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Bio-Rad Laboratories USD 6.74B 391.9M Sep/2025
Boston Scientific USD 22.65B 235M Sep/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Dexcom USD 2.73B 153M Sep/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Exact Sciences USD 2.5B 32M Sep/2025
Globus Medical USD 4.4B 103.14M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Insulet USD 1.38B 78.8M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
J&J USD 78.47B 0 Sep/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 132.96M 318K Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Terumo JPY 1.44T 68.46B Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025